Pharmaceutical Technology

Also available in: Türkçe

Assist. Prof. Dr. Yıldız ÖZALP
Assist. Prof. Dr. Metin ÇELİK
Course Code Course Name T P C M/E
EFT600 Master Thesis 4 0 4 M
EFT601 Seminar 0 2 0 M
EFT602 Pre-formulation 3 0 3 E
EFT603 Pre-formulation- Practical 0 2 1 E
EFT604 Stability 3 0 3 E
EFT605 Stability – Practical 0 2 1 E
EFT606 Physical Pharmacy 2 0 2 E
EFT607 Pharmaceutical Excipients 3 0 3 E
EFT608 Process Validation 3 0 3 E
EFT609 Evaluation and Formulation Design of Solid Dosage Forms I 3 0 3 E
EFT610 Evaluation and Formulation Design of Solid Dosage Forms II 3 0 3 E
EFT611 Evaluation and Formulation Design of Solid Dosage Forms– Practical 0 3 1 E
EFT612 Product Registration and Patents 3 0 3 E
EFT613 Basic Pharmacocinetic and Biopharmaceutics 3 0 3 E
EFT614 Basic Pharmacocinetic and Biopharmaceutics-Practical 0 2 1 E
EFT615 Good Manufacturing Practice (GMP) and Validation 3 0 3 E
EFT616 Dissolution and Release Kinetics of Pharmaceutical Solid Dosage Forms 3 0 3 E
EFT617 Dissolution and Release Kinetics of Pharmaceutical Solid Dosage Forms-Practical

 

0 2 1 E
EFT618 Basic Calculations in Pharmaceutical Technology 3 0 3 E
EFT619 Basic Calculations in Pharmaceutical Technology – Practical 0 2 1 E
EFT620 Parenteral Solutions and Other Sterile Products Technology 3 0 3 E
EFT621 Parenteral Solutions and Other Sterile Products Technology-Practical 0 2 1 E
EFT622 Computer Programming in Pharmaceutical Area 3 0 3 E
EFT623 Computer Programming in Pharmaceutical Area-Practical 0 2 1 E
EFT624 Radiopharmaceuticals  I 3 0 3 E
EFT625 Pharmaceutical Biotechnology I: Basic Principals 2 0 2 E
EFT626 Multiphase Systems I 3 0 3 E
EFT627 Multiphase Systems  I Practical 0 2 1 E
EFT628 Controlled Release Technology 3 0 3 E
EFT629 Controlled Release Technology – Practical 0 2 1 E
EFT630 Semisolid Dosage Forms 3 0 3 E
EFT631 Semisolid Dosage Forms -Practical 0 2 1 E
EFT632 Pharmaceutical Biotechnology II: Monoclonal Drug Carrier systems 1 0 1 E
EFT633 Hot Topics in Pharmaceutical Technology 3 0 3 E
EFT634 Use of  Artificial Intelligence in Pharmaceutical Technology  I – Practical 0 2 1 E
EFT635 Artificial Neural Networks, Fuzzy Logic and Fuzzy-Neural Network  I 3 0 3 E
EFT636 Pharmaceutical Compaction Tecnology I 3 0 3 E
EFT637 Pharmaceutical Compaction Tecnology I – Practical 0 3 1 E
EFT638 Design Qualification and Process Analytic Technology (QbD and PAT) – I 3 0 3 E
EFT 600
Master thesis study

EFT 601
In general, course is based on gaining assesment on literature research and evaluation skills. Teaching methods and practices of information investigation that can help master thesis or any other selected topics.

EFT 602
Basic approaches and analytical determination of incompatibility and stability evaluation of formulation studies.

EFT 603
Learning incompatibility and stability testing by discussion

EFT 604
Inportance of keeping the drug in the certain storage conditions to estimate whether it can stay or not in the limits specified for the shelf life. The rules of the ICH Guideline about the subject.

EFT 605
Teaching stability testing and result evaluation by discussion.

EFT 606
Fundemantal pharmaceutical processes

EFT 607
Major and minor pharmaceutical excipients in formulation design; their properties and their manufacturer.

EFT 608
Critical parameters of formulation and process development in industrial pharmacy, validaiton of the critical parameters and importance of their transfer to production.

EFT 609
Recognition of features and functions of pharmaceutical excipients, selection and evaluation of the excipient. Advantages and disadvantages of production method, critical points in formulation design and evaluation of the dissolution rate.

EFT 610
Recognition of features and functions of pharmaceutical excipients, selection and evaluation of the excipient. Advantages and disadvantages of production method.

EFT 611
Evaluation of the results by determining production equipments, inprocess control equipments and specifications

EFT 612
In the beginning of a new period in Turkey about pharmaceutical manufacturing and marketing by implementation of data protection and the application of patent law; patent protection and related definitions, examples of process and formulation patents will be studied.

EFT 613
Basic definitions and information about pharmacocinetic and biopharmaceutics will be studied.tir.

EFT 614
Basic definitions and information about pharmacocinetic and biopharmaceutics will be studied.

EFT 615
GMP in pharmaceutical manufacture and basic information in related guidelines will be studied.

EFT 616
Dissolution rate, parameters effecting the dissolution rate, determination of the dissolution media, basic dissolution information and release kinetics will be studied.

EFT 617
The importance of rate of dissolution in formulation development, dissolution rate test methods given in pharmacopoeias, dissolution medias, evaluation of the release kinetics calculation in drugs and interpretation of in-vitro results will be studied.

EFT 618
Basic steps and importance of drug preparation and drug production will be taught.

EFT 619
Basic steps and importance of drug preparation and drug production will be discussed.

EFT 620
Explanation of formulation and process technologies of sterile and parenteral preparations and their sterilization techniques.

EFT 621
Preparation and sterilization techniques of sterile and non sterile liquid forms in practice.

EFT 622
Introduction of computer programs which contains drug information and which can make kinetic calculations.

EFT623
Introduction and practice of computer programs which can perform kinetic calculations.

EFT 624
Examples of radiopharmaceutical drugs, basic definitions and principles of preparing will be studied.

EFT 625
The importance of biotechnology in pharmaceutical technology, protein structures, basic information about analyisis methods will be taught.

EFT 626
Examples of multiphase systems, production technologies and formulation information will be explained.

EFT 627
Examples of multiphase systems, production technologies and formulation information will be explained.

EFT 628
Process technology, importance of active substance (API) selection, mechanism of action according to formulation and analytical methods of controlled release drugs will be examined.

EFT 629
Process technology, importance of active substance (API) selection and analytical methods of controlled release drugs will be examined.

EFT 630
Examples of semi solid pharmaceutical forms will be given. Also basic knowledge about formulation properties, preparation tecniques, process characteristics and the equipments will be studied.

EFT 631
Examples of semi solid pharmaceutical forms will be given. Also basic knowledge about formulation properties, preparation tecniques, process characteristics and the equipments will be studied.

EFT 632
Study of recent developments in biotechnology; monoclonal anticor technology, production methods of monoclonal anticores, mechanism of action, purification. Introductıon to the basic concepts and knowledge in biotechnology with legal regulations, use of monoclonal anticores in pharmaceutical technology.

EFT 633
Disscussion of the developments in various fields of pharmaceutical technology in recent years.

EFT 634
Artificial intelligence and simulation techniques and their applications in various fields of pharmaceutical technology will be studied

EFT 635
Artificial intelligence and simulation techniques and their applications in various fields of pharmaceutical technology will be studied.

EFT 636
Compaction characteristics and deformation mechanism of the powders. Discussion of research methods of the mechanisms, effect of the compression and compaction of powder on product quality.

EFT 637
Compaction characteristics of powders and their deformation mechanisms will be studied practically.

EFT 638
Introduction to Quaty by Design (QbD) and Process Analytical Technology (PAT). Teaching of product and process development basic knowledge with QBD and PAT approach.

Course Code Course Name T P C M/E
EFT 700 PhD Thesis 5 0 5 M
EFT 701 Drug Targeting and Carrier Systems 3 0 3 E
EFT 702 Bioavailablity and Bioequivalancy 3 0 3 E
EFT 703 Solid Dosage Forms Technology 3 0 3 E
EFT 704 Solid Dosage Forms Technology – Practical 0 3 1 E
EFT 705 Quality Assuarance and Validation 3 0 3 E
EFT 706 Solid State Pharmaceuticals (Micromeritics) 3 0 3 E
EFT 707 Drug Targeting and Carrier Systems – Practical 0 2 1 E
EFT 708 Transdermal and Transmucozal Drug Carrier Systems 3 0 3 E
EFT 709 Transdermal and Transmucozal Drug Carrier Systems Practical   0 2 1 E
EFT 710 Pharmaceutical Biotechnology III – Peptide and Protein Formulations 2 0 2 E
EFT 711 Nonlinear Pharmacokinetic 2 0 2 E
EFT 712 Clinic Pharmacokinetic 3 0 3 E
EFT 713 Clinic Pharmacokinetic- Practical 0 2 1 E
EFT 714 Coating Technology and Microencapsulation 3 0 3 E
EFT 715 Coating Technology and Microencapsulation-Practical 0 2 1 E
EFT 716 Radiopharmaceutics II 3 0 3 E
EFT 717 Analysis of In Vivo Studies 2 0 2 E
EFT 718 Analysis of In Vivo Studies – Practical 0 2 1 E
EFT 719 Pharmaceutical Nanotechnology 2 0 2 E
EFT 720 Controlled Release Technology  II 3 0 3 E
EFT 721 Controlled Release Technology Practical II 0 2 1 E
EFT 722 Use of  Artificial Intelligence in Pharmaceutical Technology  II – Practical 0 3 1 E
EFT 723 Artificial Neural Networks, Fuzzy Logic and Fuzzy-Neural Network II 3 0 3 E
EFT 724 Pharmaceutical Compaction Tecnology II 3 0 3 E
EFT 725 Pharmaceutical Compaction Tecnology II-Practical 0 3 1 E
EFT 726 Design Qualification and Process Analytic Technology (QbD and PAT) II 3 0 3 E
EFT 727 Seminar 0 2 0 M

EFT 700
Doctorate thesis study

EFT 701
Targeting, targeting mechanisms, advantages – disadvantages and basic concepts in drug targeting will be studied.

EFT 702
Discussion of basic concepts and information related to bioavailability and bioequivalance, bioavailability comparisons, statistical methods and criteria for for bioequivalance . Relation of pharmaceutical and therapeutic equivalence with dissolution rate and bioavailability.

EFT 703
Basic consepts on solid dosage forms and their production techniques, general characteristics of powders, determination of dynamic properties of powders, granulation methods, tablet production technolgy, coating technology, coated tablets, hard gelatin capsules, and their formulations, quality control tests will be studied.

EFT 704
Formulation and optimization study of the solid dosage forms for parametric investigation of production methods.

EFT 705
Study of basic concepts about quality control and validation by discussion. Quality assurance, security,efficiency, validation types (retrospective, prospective), validation in different dosage forms, quality control,quality assurance and storage conditions are other topics of the course.

EFT 706
Basic concepts on micrometry, importance of particle size and distrubition in pharmaceutical technology.

EFT 707
Targeting, Targeting mechanism, advantages, disadvantages and basic concepts in drug targeting will be
studied.

EFT 708
Study of basic principals of Trandermal and Transmucozal Drug Carrier Systems, their passing barriers penetration methods formulations function of exipients finish product.

EFT 709
Study of basic principals of Trandermal and Transmucozal Drug Carrier Systems, their passing barriers penetration methods formulations function of exipients finish product.

EFT 710
Peptide and protein drug delivery systems and related concepts, new approaches to delivery of peptide and protein drugs into the body, giving information about the work of the formulation in order to increase the absorption and stability

EFT 711
Non-linear pharmacokinetics basic concepts, non-linear drugs and dose-response relation will be studied.

EFT 712
Learning the basic concepts and information related to clinical pharmacokinetic, changes of
pharmacodynamic parameters in young and elderly people, drug monitoring, kidneys and hepatic performance effect on the pharmacokinetics of the drug, dosage calculations, drug interactions

EFT 713
Learning the basic concepts and information related to clinical pharmacokinetic, changes of
pharmacodynamic parameters in young and elderly people, drug monitoring, kidneys and hepatic performance effect on the pharmacokinetics of the drug, dosage calculations, drug interactions

EFT 714
Basic concepts and information related to coating technology, reasons for coating, coating methods,microcapsulation preparation technologies, equipment and excipient selection according to the active substance.

EFT 715
Practical approach to basic concepts and information related to coating technology, reasons for coating, coating methods, microcapsulation preparation technologies, equipment and excipient selection according to the active substance.

EFT 716
Discussion of basic principles about radiopharmaceutics. Study of formulation, importance of exipients in the formulation.

EFT 717
Study of basic chromotographic concepts, seperation techniques basics of HPLC and determination of the suitable method to analyse biological methods.

EFT 718
Study of basic chromotographic concepts, seperation techniques basics of HPLC and determination of the suitable method to analyse biological methods.

EFT 719
Brief İntroduction to nanotechnology in basic drug delivery systems.

EFT 720
Reasons for sustained release preparations, basic concepts about formulation design and study of calculation methods in detail .

EFT 721
Reasons for sustained release preparations, basic concepts about formulation design and study of calculation methods in detail.

EFT 722
Artificial intelligence and simulation techniques and their applications in various fields of pharmaceutical technology will be studied.

EFT 723
Artificial intelligence and simulation techniques and their applications in various fields of pharmaceutical technology will be studied.

EFT 724
Compaction characteristics and deformation mechanism of the powders. Discussion of research methods of the mechanisms, effect of the compression and compaction of powder on product quality.

EFT 725
Compaction characteristics of powders and their deformation mechanisms will be studied practically.

EFT 726
Introduction to Quality by Design (QBD) and Process Analytical Technology (PAT). Teaching of product and process development basic knowledge with QBD and PAT approach.

EFT 727
In general, course is based on gaining assesment on literature research and evaluation skills. Teaching methods and practices of information investigation that can help master thesis or any other selected topics